Changes in early and late diastolic filling patterns induced by long- term adrenergic β-blockade in patients with idiopathic dilated cardiomyopathy

Circulation

Volumn 94, Issue 4, 1996, Pages 673-682

  Andersson, Bert ^a,g   Caidahl, Kenneth ^a   Di Lenarda, Andrea ^b   Warren, Sanford E ^c   Goss, Franz ^d   Waldenström, Anders ^e   Persson, Stig ^f   Wallentin, Ingemar ^a   Hjalmarson, Åke ^a   Waagstein, Finn ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b MAGGIORE HOSPITAL   (Italy)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d Zentralklinikum ^*  (Germany)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY   (Sweden)

^g Sahlgrenska Sjukhuset   (Sweden)

Author keywords

cardiomyopathy; diastole; echocardiography; heart failure; recep tors, adrenergic,beta; systole

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; METOPROLOL; NITRATE; PLACEBO; TECHNETIUM 99M;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART DILATATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART RATE; HEMODYNAMICS; HUMAN; LONG TERM CARE; LUNG CAPILLARY PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; R WAVE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SYSTOLE;

EID: 9544224161     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.4.673     Document Type: Article

References (51)

1. Plotnick GD. Changes in diastolic function: difficult to measure, harder to interpret. Am Heart J. 1989;118:637-641.
2. Kapuku GK, Seto S, Mori H, Mori M, Utsunomia T, Suzuki S, Oku Y, Yano K. Reversal of diastolic dysfunction in borderline hypertension by long-term medical treatment: longitudinal evaluation by pulsed Doppler echocardiography. Am J Hypertens. 1993;6:547-553.
3. Kjekshus JK. Importance of heart rate determining β-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol. 1986;57:43F-49F.
4. Klevans LR, Kovacs JL, Kelly R. Central effect of β-adrenergic blocking agents on arterial blood pressure. J Pharmacol Exp Ther. 1976;196:389-395.
5. Mueller HS. Propranolol in acute myocardial infarction in man: effects of hemodynamics and myocardial oxygenation. Acta Med Scand. 1976;(suppl 587):177-183.
6. Boudoulas H, Rittgers SE, Lewis RP, Leier CV, Weissler AM. Changes in diastolic time with various pharmacologic agents. Circulation. 1979;60:164-169.
7. Sethi KK, Nair M, Arora R, Khalilullah M. Oral metoprolol therapy in dilated cardiomyopathy: hemodynamic evidence for improved diastolic function accompanying amelioration of symptoms. Int J Cardiol. 1990;29:317-322.
8. Stoleru L, Wijns W, Vaneyll C, Bouvy T, Vannueten L, Pouleur H. Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol. J Cardiovasc Pharmacol. 1993;22:183-190.
9. Sugiura T, Iwasaka T, Hasegawa T, Takabashi N, Matsutani M, Inada M. Effect of propranolol on diastolic time during exercise. J Cardiovasc Pharmacol. 1990;15:371-376.
10. Erlebacher JA, Bhardwaj M, Suresh A, Leber GB, Goldweit RS. Beta-blocker treatment of idiopathic and ischemic dilated cardiomyopathy in patients with ejection fractions ≤20%. Am J Cardiol. 1993;71:1467-1469.
11. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson Å. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 1993;342:1441-1446.
12. Anderson JL, Gilbert EM, O'Connell JB, Renlund D, Yanowitz F, Murray M, Roskelley M, Mealey P, Volkman K, Deitchman D, Bristow M. Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1991;17:1373-1381.
13. Engelmeier RS, O'Connell JB, Walsh R, Rad N, Scanlon PJ, Gunnar R. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Circulation. 1985;72:536-546.
14. Woodley SL, Gilbert EM, Anderson JL, O'Connell JB, Deitchman D, Yanowitz FG, Mealey PC, Volkman K, Renlund DG, Menlove R, Bristow MR. β-Blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation. 1991;84:2426-2441.
15. Andersson B, Lomsky M, Waagstein F. The link between acute haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure. Eur Heart J. 1993;14:1375-1385.
16. Haber HL, Simek CL, Gimple LW, Bergin JD, Subbiah K, Jayaweera AR, Powers ER, Feldman MD. Why do patients with congestive heart failure tolerate the initiation of β-blocker therapy? Circulation. 1993;88:1610-1619.
17. Swedberg K, Hjalmarson Å, Waagstein F, Wallentin I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J. 1980;44:117-133.
18. Swedberg K, Hjalmarson Å, Waagstein F, Wallentin I. Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy. Br Heart J. 1980;44:134-142.
19. Waagstein F, Hjalmarson Å, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975;37:1022-1036.
20. Waagstein F, Caidahl K, Wallentin I, Bergh C-H, Hjalmarson Å. Long-term β-blockade in dilated cardiomyopathy: effects of shortand long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation. 1989;80:551-563.
21. Chen C, Rodriguez L, Levine RA, Weyman AE, Thomas JD. Noninvasive measurement of the time constant of left ventricular relaxation using the continuous-wave Doppler velocity profile of mitral regurgitation. Circulation. 1992;86:272-278.
22. Nishimura RA, Schwartz RS, Tajik AJ, Holmes DR. Noninvasive measurement of rate of left ventricular relaxation by Doppler echocardiography: validation with simultaneous cardiac catheterization. Circulation. 1993;88:146-155.
23. Milliken GA. Analysis of messy data. In: Volume I: Designed Experiments. Belmont, Calif: Lifetime Learning Publications; 1984:384-397.
24. Thomas JD, Weyman AE. Echocardiographic Doppler evaluation of left ventricular diastolic function. Circulation. 1991;84:977-990.
25. Flachskampf FA, Weyman AE, Guerrero JL, Thomas JD. Calculation of atrioventricular compliance from the mitral flow profile: analytic and in vitro study. J Am Coll Cardiol 1992;19:998-1004.
26. Ohno M, Cheng C-P, Little WC. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation. 1994;89:2241-2250.
27. Little WC, Ohno M, Kitzman DW, Thomas JD, Cheng C-P. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation. 1995;92:1933-1939.
28. Eichhorn EJ, Bedotto JB, Malloy CR, Hatfield BA, Deitchman D, Brown M, Willard JE, Grayburn PA. Effect of β-adrenergic blockade on myocardial function and energetics in congestive heart failure. Circulation. 1990;82:473-483.
29. Lavine SJ, Arends D. Importance of the left ventricular filling pressure on diastolic filling in idiopathic dilated cardiomyopathy. Am J Cardiol. 1989;64:61-66.
30. Myreng Y, Smiseth OA, Risøe C. Left ventricular filling at elevated diastolic pressures: relationship between transmitral Doppler flow velocities and atrial contribution. Am Heart J. 1990;119:620-626.
31. Stoddard MF, Pearson AC, Kern MJ, Ratcliff J, Mrcsek DG, Labovitz AJ. Left ventricular diastolic function: comparison of pulsed Doppler echocardiographic and hemodynamic indexes in subjects with and without coronary artery disease. J Am Coll Cardiol. 1989;13:327-336.
32. Andersson B, Blomström-Lundqvist C, Hedner T, Waagstein F. Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol. 1991;18:1059-1066.
33. Andersson B, Hamm C, Persson S, Wikström G, Sinagra G, Hjalmarson A, Waagstein F. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol. 1994;23:1397-1404.
34. Courtois M, Mechem CJ, Barzilai B, Ludbrook PA. Factors related to end-systolic volume are important determinants of peak early diastolic transmitral flow velocity. Circulation. 1992;85:1132-1138.
35. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol. 1995;25:1154-1161.
36. Andersson B, Strömblad S-O, Lomsky M, Waagstein F. Heart rate independent evaluation of systolic and diastolic function in dilated cardiomyopathy during long-term metoprolol therapy. Heart Failure '95. 1995;33.
37. Boerth RC, Covell JW, Pool PE, Ross J. Increased myocardial oxygen consumption and contractile state associated with increased heart rate in dogs. Circ Res. 1969;24:725-734.
38. Hammermeister KE, Warbasse JR. The rate of change of left ventricular volume in man. Circulation. 1974;49:739-747.
39. Mulieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR. Altered myocardial force-frequency relation in human heart failure. Circulation. 1992;85:1743-1750.
40. Shen WF, Tribouilloy C, Rey JL, Baudhuin JJ, Boey S, Dufosse H, Lesbre JP. Prognostic significance of Doppler-derived left ventricular diastolic filling variables in dilated cardiomyopathy. Am Heart J. 1992;124:1524-1533.
41. Pinamonti B, Di Lenarda A, Sinagra G, Camerini F, and the Heart Muscle Disease Study Group. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. J Am Coll Cardiol. 1993;22:808-815.
42. Werner GS, Schaefer C, Dirks R, Figulla HR, Kreuzer H. Doppler echocardiographic assessment of left ventricular filling in idiopathic dilated cardiomyopathy during a one-year follow-up: relation to the clinical course of disease. Am Heart J. 1993;126:1408-1416.
43. Xie G-Y. Berk MR, Smith MD, Gurley JC, DeMaria AN. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol. 1994;24:132-139.
44. Harrison MR, Clifton D, Pennell AT, DeMaria AN. Effect of heart rate on left ventricular diastolic transmitral flow velocity patterns assessed by Doppler echocardiography in normal subjects. Am J Cardiol. 1991;67:622-627.
45. Eichhorn EJ, Heesch CM, Barnett JH, Alvarez LG, Fass SM, Grayburn PA, Hatfield BA, Marcoux LG, Malloy CR. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebocontrolled study. J Am Coll Cordiol. 1994;24:1310-1320.
46. Eichhorn EJ, Heesch CM, Risser RC, Marcoux L, Hatfield B. Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol. J Am Coll Cardiol. 1995;25:154-162.
47. Colan SD, Borow KM, Neumann A. Effects of loading conditions and contractile state (methoxamine and dobutamine) on left ventricular early diastolic function in normal subjects. Am J Cardiol. 1985;55:790-796.
48. 1-adrenoceptor blockade on hemodynamic and myocardial metabolic effects of enoximone and dobutamine in patients with chronic severe heart failure. Heart Failure '95. 1995;77. Abstract.
49. 2+ channel antagonists in an animal model of dilated cardiomyopathy. Circ Res. 1993;73:1077-1089.
50. i in quiescent ventricular myocardium. Cardiovasc Res. 1995;28:112-118.
51. Neubauer S, Krahe T, Schindler R, Horn M, Hillenbrand H, Entzeroth C, Mader H, Kromer EP, Riegger GAJ, Lackner K. P-31 magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: altered cardiac high-energy phosphate metabolism in heart failure. Circulation. 1992;86:1810-1818.